Finance

Beta
Lists
GLSI:NASDAQ
Greenwich Lifesciences Inc
$23.67
-2.55%
(-0.62) 1D
$22.76
-3.84% (-0.91)
After hours
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GLSI...
Open
$23.62
High
$24.93
Low
$22.40
Mkt. cap
347.43M
Avg. vol.
137.50K
Volume
0.00
52-wk high
$34.10
52-wk low
$7.78
EPS
-$1.43
Beta
1.40
Shares outstanding
14.68M
No. of employees
4
Open
$23.62
High
$24.93
Low
$22.40
Mkt. cap
347.43M
Avg. vol.
137.50K
Volume
0.00
52-wk high
$34.10
52-wk low
$7.78
EPS
-$1.43
Beta
1.40
Shares outstanding
14.68M
No. of employees
4
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to GLSI in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for GLSI in the last 3 months.
Highest
Current $23.67
$50.00 (+111.24%)
Average
$47.50 (+100.68%)
Lowest
$45.00 (+90.11%)
News stories
From sources across the web
About Greenwich Lifesciences Inc
CEO-
Employees4
Founded2006
HeadquartersStafford, Texas, United States
SectorBiotechnology
Websitegreenwichlifesciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.60M
3.51M
3.52M
7.59M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
681.21K
538.05K
653.07K
355.19K
Operating expense
3.28M
4.05M
4.17M
7.94M
Total operating expenses
3.28M
4.05M
4.17M
7.94M
Operating income
-3.28M
-4.05M
-4.17M
-7.94M
Other non operating income
-
-
-
-
EBT including unusual items
-3.26M
-4.03M
-4.15M
-7.92M
EBT excluding unusual items
-3.26M
-4.03M
-4.15M
-7.92M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.26M
-4.03M
-4.15M
-7.92M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
23.97K
20.68K
22.80K
22.26K
Interest expense
-
-
-
-
Net interest expenses
23.97K
20.68K
22.80K
22.26K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.28M
-4.05M
-4.17M
-7.94M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer